-
28 July 2022
-
28 July 2022
-
09 February 2023
-
09 February 2023
Ipsen presents strong full-year 2022 results and guidance for 2023
Paris (France), 9 February 2023...
-
27 October 2022
-
27 October 2022
Ipsen delivers strong sales growth in the first nine months of 2022 and confirms its full-year guidance
Paris (France), 27 October 2022...
-
28 July 2022
-
28 July 2022
Ipsen delivers strong H1 2022 results and upgrades its full-year guidance
Paris (France), 28 July 2022 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical company, presents its financial results for the first half of 2022:...
-
05 May 2021
-
05 May 2021
Assemblée Générale Mixte du 27 mai 2021
Boulogne-Billancourt (France), le 5 mai 2021 – Dans le contexte de l’épidémie de Covid-19 etconformément à l’Ordonnance n°2020-321 du 25 mars 2020 (telle que prorogée et modifiée par l’ordonnance n°2020-1497 du 2 décembre 2020) et au Décr...
-
21 October 2021
-
21 October 2021
-
22 April 2021
-
22 April 2021
-
26 July 2021
-
26 July 2021
-
07 May 2020
-
07 May 2020
-
17 April 2019
-
17 April 2019
Assemblée Générale Mixte du 28 mai 2019
All the resolutions submitted to the Shareholder’s vote have been approved....